A fourth protein, thyroid-stimulating hormone receptor (TSHR), is the target of a biologic that has been indicated as a diagnostic and adjuvant therapy to avoid hypothyroidism after thyroid ablation in patients with thyroid cancer.
Cranial ultrasonography is not indicated as a diagnostic modality for the evaluation of AHT.
This tool clusters various ICD-9 diagnoses into a manageable number of meaningful categories [ 12], indicated as 'CCS diagnostic groups'.
Nevertheless, collagen VI is indicated as a diagnostic serum marker of patients with melanoma and pancreatic cancer, since the levels of this protein in human sera are significantly increased in both aggressive malignant tumours with respect to healthy donors.
However, in these guidelines, A1C is indicated as a diagnostic tool alternative but not superior to blood glucose, leaving to the health care professional the decision about what test to use in an individual.
A maternal-only contribution is diagnostic of PWS, while an exclusively paternal contribution indicates AS.
Furthermore, an European survey on the clinical management of nodular thyroid lesions showed that thyroid FNA-cytology was indicated as the first diagnostic procedure by 41% of the responders, if they had to choose only one diagnostic test, and by only 25% when more than one test could be considered (Baldet et al, 1989).
MRI is not indicated as an initial diagnostic test for SAH but may be useful when the CT is normal and the CSF abnormal [42].
Finally, miR-16, miR-132, and miR-223 were also shown to have an altered expression in RA patients, indicating their potential as diagnostic biomarkers for pathogenesis [ 83, 88, 91].
On the other hand, LRs outside a second arbitrary threshold (LR+ >8, LR- <0.2) were considered to indicate a strong diagnostic association, and indicated as such in our conclusions [ 11, 12].
